Re: ZEN-3694 mCRPC Trial Status
in response to
by
posted on
Oct 24, 2017 04:55PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Yes, I think the Zenith data looks very promising and I am optimistic of more good news coming out between now and year's end.
A better BET than RVX? I like 'em both. Double down!
BearDownAZ